Genesis Molecular AI is a biotechnology company pioneering AI-driven drug discovery through its proprietary GEMS platform. The company develops cutting-edge medicines by combining advanced AI foundation models like Pearl with biotech expertise to identify highly potent and selective drug candidates against challenging protein targets.
GEMS, the AI Operating System for drug discovery, empowers scientists to unlock tough protein targets and invent medicines with unprecedented potency and selectivity at industry-leading speed.
AI Visibility Score
Genesis Molecular AI has an AI visibility score of 26/100, rated as low. This score reflects how often and how prominently Genesis Molecular AI appears in responses from AI assistants like ChatGPT, Claude, and Gemini.
AI Perception Summary
Genesis Molecular AI possesses a potent technical edge, securing top-tier rankings for specialized 3D diffusion and generative modeling queries, yet it remains effectively invisible to the R&D executives who authorize high-value pharma partnerships. While the brand commands authority among computational biologists, its failure to penetrate broader 'best-of' lists and AI Overviews allows legacy competitors like Exscientia and Schrödinger to monopolize the commercial narrative.
Strengths
- High technical authority with the Lead Computational Biologist persona, achieving a 48% mention rate.
- Dominant rankings on high-intent technical queries, including #1 positions for 3D diffusion models and high-potency drug discovery platforms on Gemini and ChatGPT.
- Perfect 'brand vibe check' performance, showing that when the brand is known, the AI models characterize it accurately and positively.
Visibility Gaps
- Critical visibility vacuum among R&D Efficiency Executives (6% mention rate), the primary decision-makers for enterprise adoption.
- Complete absence from foundational category queries such as 'reputable AI biotech companies' and 'best AI tools for targeting protein targets.'
- Poor performance in AI Overviews with a low 13% mention rate and a deep average position of 15.0, limiting discovery for search-based AI users.
Competitors in AI Recommendations
- Exscientia: 82 mentions
- Schrödinger: 73 mentions
- Atomwise: 61 mentions
- Insilico Medicine: 60 mentions
- Recursion Pharmaceuticals: 55 mentions
- DeepMind: 39 mentions
- BenevolentAI: 38 mentions
- AlphaFold: 35 mentions
- Isomorphic Labs: 28 mentions
- AtomNet: 26 mentions
- Recursion: 20 mentions
- Benchling: 20 mentions
- Roche: 20 mentions
- NVIDIA: 19 mentions
- DiffDock: 17 mentions
Categories: Biotechnology